| PMID | Title | Display |
|---|
| 10100207 | Suppression of acidic fibroblast growth factor-dependent angiogenesis by the antigrowth activity of 1,3,6-naphthalenetrisulfonate. |    |
|
| 10398144 | Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. | |
|
| 10501915 | Antiangiogenic potential of camptothecin and topotecan. | |
|
| 10629854 | [Involvement of chymase in angiogenesis in hamster sponge granulomas]. | |
|
| 10679822 | A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. | |
|
| 10681534 | Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. | |
|
| 10816345 | The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. | |
|
| 10821793 | Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. | |
|
| 10859480 | Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. | |
|
| 10896819 | Wound healing: captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan. | |
|
